Protocol Ledger

NCT05836987 · Phase III · RECRUITING

The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Interventional Phase III clinical trial protocol NCT05836987 sponsored by Johns Hopkins University in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-07-13 Enrollment: 5,350 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05836987
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)5,350 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05836987
Protocol FieldVerified Registry Value
NCT IdentifierNCT05836987
Consolidated Lead SponsorJohns Hopkins University
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment5,350 participants (ESTIMATED)
Registered Start Date2023-07-13
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Johns Hopkins Medicine across sibling Meru public-data platforms.

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI